Allison D. Edwards, ARNP
Nurse Practitioners (Family Nurse Practitioner)
- Medicare participating
At a glance
- Years since graduation
- 10
- In the NPI registry since
- 2017
- Medicare patients seen, 2024
- 19
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2017Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Nurse Practitioner primary
FL license ARNP9319269 -
Gerontology Nurse Practitioner
FL license ARNP9319269 -
Nurse Practitioner
FL license ARNP9319269
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Pensacola Nephrology PA (37 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 19
- Services billed
- 28
- Patients’ average age
- 66
| Service | Times | Patients |
|---|---|---|
| Dialysis services, 4 or more physician visits per month (20 years or older) | 42 | 36 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Sevelamer Carbonate Other prescribers in Pensacola, FL | 27 |
| Velphoro (sucroferric oxyhydroxide) | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 3 payments worth $231 in total to this clinician.
| Amgen Inc. | $122 |
|---|---|
| Novo Nordisk Inc | $93.19 |
| GlaxoSmithKline, LLC. | $16.40 |
| Food and Beverage | $231 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.